COMPANY PROFILE

Generation Lab

Comprehensive genomics testing for personalized longevity strategies based on epigenetic insights and biomolecular evidence

Burlingame, United StatesFounded 2023Biotech & Life Sciences

Valuation $50–100M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Generation Lab

Generation Lab specializes in advanced genomics testing to provide personalized strategies for longevity and health optimization. The company operates in the field of aging and regenerative medicine, offering services that analyze biological age across 19 different organs and systems. By utilizing DNA methylation detection, Generation Lab identifies biomarkers that indicate aging rates and disease risks. Clients receive customized lifestyle strategies or treatments based on their unique epigenetic information, reviewed with healthcare experts. The business model focuses on providing detailed lab reports and consultations, generating revenue through these personalized health assessments. Generation Lab serves individuals seeking to improve and extend their quality of life, leveraging over 20 years of research and thousands of scientific citations. The company is part of a biobank initiative aimed at preventing disease and extending lifespan.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2023
Headquarters: Burlingame, United States
Employees: 30
Open positions: None listed
Dealroom signal: 92.4/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, Longevity, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Oct 2025	$11M	$44M	Samsung Next · Accel · Zone II Ventures · Aoki Labs	↗
SEED✓Equity / VC	Jan 2024	$0	—	HSG · Transpose Platform	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Generation Lab website traffic

Latest recorded traffic for Generation Lab is 23K monthly website visits, up 64.3% over the last three months. Generation Lab's team grew 50% over the past year.

Latest monthly visits23K 3-month web change+64.3% 1-year team growth+50%

Monthly website visitsDec 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CRCell Biopeutics ResourcesCommercializing mesenchymal stem cell therapeutics and cosmetics	Kuala Lumpur, Malaysia	Operational	10	$1.1M	$4.4M
FBFoundry BioSciencesProtein engineering with AI to extend longevity and elevate quality of life	Boston, United States	Operational
EPEtheros PharmaceuticalsInnovative small molecule drugs mimicking enzymes to protect neural tissue from oxidative and inflammatory damage	Nashville, United States	Operational
EPEpiternaDeveloping affordable products that can safely slow the ageing process to prevent age-related disease, delay functional decline, and extend life	Epalinges, Switzerland	Operational
OBOra BiomedicalOra Biomedical, Inc. focuses on identifying and characterizing therapeutics for healthy aging	Seattle, United States	Operational
NTNeuroAge TherapeuticsThis can tell you whether you are on the right track to stay sharp and avoid dementia	San Francisco, United States	Operational
EBEntact BioA preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins	Watertown, United States	Operational
IMImmunisA private biotechnology company focused on the development of treatments for age-related and disease-related immune deficits	Irvine, United States	Operational